Home › Trial NCT06495749
Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures
- Trial IDNCT06495749
- StatusNot Yet Recruiting
- PhaseN/A
- Study typeObservational
- SponsorZhejiang University
- Enrollment3000
- Start date2024-08-01
- ConditionsPancreatic Cancer Resectable
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.